Toxic Epidermal Necrolysis After Carbamazepine Use in Trigeminal Neuralgia: A Case Report

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, potentially life-threatening mucocutaneous reactions, most commonly associated with medication exposure.Early recognition, immediate discontinuation of the suspected causative drug, and intensive supportive care are essential for clinical management.We report the case of a 55-year-old woman who developed TEN following carbamazepine treatment for trigeminal neuralgia.Approximately 24 days after initiating carbamazepine at 200 mg/day, the patient developed malaise, severe pruritus, and erythematous lesions initially affecting the face and trunk.Over the following days, the lesions progressed rapidly to widespread blistering, erosions, and epidermal detachment, with approximately 55% of the body surface area clinically affected.Oral, ocular, and genital mucosal involvement resulted in severe pain, dysphagia, odynophagia, dysuria, dehydration, and conjunctival complications.Carbamazepine was discontinued, and treatment consisted of intensive supportive care, including intravenous and enteral hydration, opioid analgesia, wound and mucosal care, nutritional support, and multidisciplinary management.A nasoenteric feeding tube and urinary catheter were temporarily required because of severe mucosal involvement.Systemic corticosteroids and other systemic immunomodulatory therapies were not administered.The patient showed progressive clinical improvement, with substantial resolution of cutaneous and mucosal lesions, and was discharged with outpatient follow-up recommendations.This case highlights the importance of recognizing severe cutaneous adverse reactions associated with carbamazepine, particularly during the first weeks of treatment.It also illustrates the role of early drug withdrawal, comprehensive supportive care, adequate pain control, and multidisciplinary management in achieving a favorable clinical outcome, even in patients with extensive epidermal involvement.

Authors

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119600
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Toxic Epidermal Necrolysis After Carbamazepine Use in Trigeminal Neuralgia: A Case Report

Giovani Caldas Gnoato, Luiza Horta B Juda
Cureus
Drug-Induced Adverse Reactions
article

Toxic Epidermal Necrolysis After Carbamazepine Use in Trigeminal Neuralgia: A Case Report

Giovani Caldas Gnoato, Luiza Horta B Juda
article en

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, potentially life-threatening mucocutaneous reactions, most commonly associated with medication exposure.Early recognition, immediate discontinuation of the suspected causative drug, and intensive supportive care are essential for clinical management.We report the case of a 55-year-old woman who developed TEN following carbamazepine treatment for trigeminal neuralgia.Approximately 24 days after initiating carbamazepine at 200 mg/day, the patient developed malaise, severe pruritus, and erythematous lesions initially affecting the face and trunk.Over the following days, the lesions progressed rapidly to widespread blistering, erosions, and epidermal detachment, with approximately 55% of the body surface area clinically affected.Oral, ocular, and genital mucosal involvement resulted in severe pain, dysphagia, odynophagia, dysuria, dehydration, and conjunctival complications.Carbamazepine was discontinued, and treatment consisted of intensive supportive care, including intravenous and enteral hydration, opioid analgesia, wound and mucosal care, nutritional support, and multidisciplinary management.A nasoenteric feeding tube and urinary catheter were temporarily required because of severe mucosal involvement.Systemic corticosteroids and other systemic immunomodulatory therapies were not administered.The patient showed progressive clinical improvement, with substantial resolution of cutaneous and mucosal lesions, and was discharged with outpatient follow-up recommendations.This case highlights the importance of recognizing severe cutaneous adverse reactions associated with carbamazepine, particularly during the first weeks of treatment.It also illustrates the role of early drug withdrawal, comprehensive supportive care, adequate pain control, and multidisciplinary management in achieving a favorable clinical outcome, even in patients with extensive epidermal involvement.

Cureus
Good health and well-being
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon